Solid Biosciences (SLDB) Shares Outstanding (2017 - 2026)

Solid Biosciences has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $98.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 26.97% year-over-year to $98.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.4 million (up 26.97% YoY) and the FY2025 annual result came in at $79.0 million, up 95.14% from the prior year.
• Shares Outstanding (Entity) rose to $98.4 million in Q1 2026 per SLDB's latest filing, from $79.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $98.4 million in Q1 2026 and troughed at $7.5 million in Q1 2022.
• A 5-year average of $39.8 million and a median of $37.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) rose 0.45% in 2022, then jumped 166.32% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $8.5 million in 2022, then jumped by 139.5% to $20.4 million in 2023, then jumped by 98.5% to $40.5 million in 2024, then jumped by 95.14% to $79.0 million in 2025, then gained by 24.6% to $98.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $98.4 million, $79.0 million, and $77.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.